Voya Investment Management LLC grew its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 96.5% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 153,413 shares of the company's stock after purchasing an additional 75,341 shares during the period. Voya Investment Management LLC owned approximately 0.18% of HealthEquity worth $13,557,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. Inspire Investing LLC raised its stake in HealthEquity by 8.6% in the 1st quarter. Inspire Investing LLC now owns 7,529 shares of the company's stock valued at $665,000 after purchasing an additional 597 shares during the last quarter. Hodges Capital Management Inc. purchased a new stake in shares of HealthEquity during the 1st quarter worth about $1,988,000. Strs Ohio purchased a new stake in shares of HealthEquity during the 1st quarter worth about $999,000. Mattson Financial Services LLC grew its holdings in shares of HealthEquity by 15.5% during the 1st quarter. Mattson Financial Services LLC now owns 1,988 shares of the company's stock worth $176,000 after purchasing an additional 267 shares during the period. Finally, Belpointe Asset Management LLC purchased a new stake in shares of HealthEquity during the 1st quarter worth about $756,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.
HealthEquity Stock Down 1.9%
NASDAQ HQY traded down $1.85 during trading on Friday, hitting $93.74. The stock had a trading volume of 1,600,983 shares, compared to its average volume of 1,228,123. The company has a market capitalization of $8.08 billion, a PE ratio of 56.81, a P/E/G ratio of 1.37 and a beta of 0.50. HealthEquity, Inc. has a 12 month low of $74.07 and a 12 month high of $116.65. The company's 50-day moving average price is $92.85 and its two-hundred day moving average price is $94.06. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23.
Wall Street Analyst Weigh In
HQY has been the subject of a number of analyst reports. The Goldman Sachs Group upped their price target on HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a report on Wednesday, June 4th. JPMorgan Chase & Co. boosted their price objective on HealthEquity from $125.00 to $126.00 and gave the stock an "overweight" rating in a report on Wednesday, September 3rd. Deutsche Bank Aktiengesellschaft upped their target price on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a report on Thursday, June 5th. Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a report on Friday, June 6th. Finally, Jefferies Financial Group increased their price objective on HealthEquity from $130.00 to $134.00 and gave the company a "buy" rating in a research report on Wednesday, September 3rd. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat.com, HealthEquity currently has an average rating of "Buy" and an average target price of $119.77.
View Our Latest Stock Report on HealthEquity
Insider Buying and Selling at HealthEquity
In other HealthEquity news, EVP Michael Henry Fiore sold 1,794 shares of the business's stock in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $101.73, for a total transaction of $182,503.62. Following the transaction, the executive vice president owned 53,225 shares of the company's stock, valued at $5,414,579.25. The trade was a 3.26% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.50% of the stock is owned by company insiders.
About HealthEquity
(
Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Recommended Stories

Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.